Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model
Authors:
- Justin G. JulanderJJJustin G. Julander
- John D. MorreyJMJohn D. Morrey
- Lawrence M. BlattLBLawrence M. Blatt
- Kristiina ShaferKSKristiina Shafer
- Robert W. SidwellRSRobert W. Sidwell
- 1 February 2007
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 73 (2) , 140-146
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Protective immune responses against West Nile virus are primed by distinct complement activation pathwaysJournal of Experimental Medicine, 2006
- In vitro and in vivo influenza virus-inhibitory effects of viramidineAntiviral Research, 2005
- Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and BelgiumJournal of Clinical Virology, 2005
- Interferon Alfacon-1 Protects Hamsters from Lethal Pichinde Virus InfectionAntimicrobial Agents and Chemotherapy, 2005
- Interferon Alfacon-1 and Ribavirin Versus Interferon ?-2b and Ribavirin in the Treatment of Chronic Hepatitis CDigestive Diseases and Sciences, 2005
- Modeling hamsters for evaluating West Nile virus therapiesAntiviral Research, 2004
- Yellow Fever: The Recurring PlagueCritical Reviews in Clinical Laboratory Sciences, 2004
- Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated VaccinesJournal of Virology, 2002
- Comparison of the In Vitro Host Range of Recombinant met-Interferon-con 1 , Interferon-α 2a , and Interferon-βJournal of Interferon & Cytokine Research, 1995
- Attenuation of wild-type yellow fever virus by passage in HeLa cellsJournal of General Virology, 1990